Elham B. Rostami

My research is aiming to understand the underlying pathology in different types of acute brain injuries with main focus on traumatic brain injury. We use multimodal monitoring including microdialysis in the management of TBI patients. The data generated from these monitoring in addition to clinical data are analyzed with machinelearning to identify important predictors of outcome. Our preclinical studies include different experimental TBI models, in vitro studies with drug testing as well as patient-specific iPSC and genetic analysis. Our main goal is to identify important prognostic markers and understand why some people recover better than others and what role our genetic background plays.

Since the outbreak of COVID-19 we also initiated the COVID-19-Neuro study where we strive to investigate the associated neurological complications and possible acute injures to the CNS caused by SARS-Co-2.